DRUG · Unmapped registry intervention
AK104
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
NCT05215067
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Non-small Cell Lung Cancerunresolved
Interventions
AK104DRUG
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Akesolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05215067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.